Q4 2021 · —
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$62.91M-$62.91M derivedno prior Q4 2020 on fileN/M vs Q3 2021
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Cash Flowderived-$13,187,000—
Free Cash Flowderived-$13,569,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q4 2020 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prime Medicine, Inc. · CIK 1894562 · Engraved from SEC EDGAR